Medicina Global e Humanitária

[Ainda não publicado] Pesquisadores afirmam que dose única de vacina contra HPV é altamente eficaz – “Resultado de estudo randomizado e controlado no Quênia traz novo ânimo para eliminar o câncer de colo de útero no mundo.”

22 Nov, 2021 | 09:23h

Single-dose HPV vaccine highly effective, researchers say – University of Washington School of Medicine

Conteúdos relacionados:

A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs

---

Progresso global da tuberculose foi revertido pela pandemia de COVID-19.

19 Nov, 2021 | 13:14h

Global tuberculosis progress reversed by COVID-19 pandemic – The Lancet Respiratory Diseases

Conteúdos relacionados:

WHO Report: Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic.

How COVID is derailing the fight against HIV, TB and malaria.

How COVID hurt the fight against other dangerous diseases

World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis

WHO: Benefits of continuing to provide life-saving HIV services outweigh the risk of COVID-19 transmission by 100 to 1

Tuberculosis and Covid-19: Fighting a deadly syndemic

Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study

 

Comentário no Twitter

NEWS—Global #tuberculosis progress reversed by #COVID19 pandemic

"Due to the delayed effects from #COVID19, #tuberculosis deaths are projected to rise again in 2022 while the world readjusts to a new normality and services resume."

Read more here: https://t.co/tWVXswZsvs

— The Lancet Respiratory Medicine (@LancetRespirMed) November 3, 2021

 

---

Novo relatório da OMS mapeia as barreiras à disponibilidade de insulina e sugere ações que promovam o acesso universal – “100 anos depois de sua descoberta, a insulina ainda está fora do alcance de muitos que vivem com diabetes.”

16 Nov, 2021 | 12:34h

Comunicado de imprensa: New WHO report maps barriers to insulin availability and suggests actions to promote universal access – World Health Organization

Relatório: Keeping the 100-year-old promise: making insulin access universal – World Health Organization

Comentário: Half the People Living with Diabetes Can’t Afford Insulin, WHO Report Shows – Health Policy Watch

Conteúdos relacionados:

Editorial | Insulin for all: a hope yet to be realized.

One hundred years of insulin therapy.

The state of diabetes treatment coverage in 55 low-income and middle-income countries – fewer than one in ten people with diabetes in LMICs receive comprehensive care such as low-cost medicines to reduce blood sugar, blood pressure and cholesterol levels, in addition to counseling on diet, exercise and weight.

 

Comentário no Twitter (fio – clique para saber mais)

The 🆕 WHO report on global access to #insulin shows how a century after its discovery, insulin remains inaccessible or unaffordable for many children and adults living with #diabetes around the 🌍🌎🌏.

More here 👉https://t.co/kcaqh6tYO1

— World Health Organization (WHO) (@WHO) November 12, 2021

 

---

#AHA21 – Estudo randomizado | Entre crianças e adolescentes submetidos a rastreamento ecocardiográfico e diagnosticados com doença cardíaca reumática latente, antibioticoprofilaxia secundária com penicilina G benzatina por 2 anos foi associada com redução da progressão ecocardiográfica (0,8 vs, 8,2% no grupo controle).

15 Nov, 2021 | 13:53h

Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentários:

Penicillin significantly reduces rheumatic heart disease progression in children – Murdoch Children’s Research Institute

Penicillin slows devastating impacts of rheumatic heart disease in children from Uganda – Children’s National Hospital

Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease – American College of Cardiology

 

Comentários no Twitter

One of most important studies ever Rheumatic Heart Disease @NEJM https://t.co/U8FuNHLqCJ RCT evidence 2ry prophylaxis reduces progression latent RhD pic.twitter.com/UycTElr7QM

— Michael Marks (@dr_michaelmarks) November 13, 2021

Penicillin slowed the devastating impact of rheumatic heart disease among children in Uganda. Findings of a large-scale, randomized controlled trial were completed in Uganda. Group A strep underlies rheumatic heart disease. New England Journal of Medicine https://t.co/1PKFJ12FvC

— delthia ricks 🔬 (@DelthiaRicks) November 13, 2021

 

---

Efeitos do calor extremo sobre as pessoas nas cidades em desenvolvimento: nova análise mostra que o crescimento explosivo das cidades está levando a condições perigosas.

25 Out, 2021 | 12:43h

Extreme heat is broiling people in developing cities – Science

Estudo original: Global urban population exposure to extreme heat – Proceedings of the National Academy of Sciences

 

Comentário no Twitter

People in major cities are exposed to deadly temperatures 3X more often than in the 1980s—with cities in South Asia, Africa, and the Middle East bearing the brunt, according to a new analysis of 13,000+ cities. https://t.co/C864clE4Cq

— Global Health NOW (@ghn_news) October 9, 2021

 

---

Infecções adquiridas em instituições de cuidado à saúde em países de média e baixa rendas e o papel da prevenção e do controle de infecções.

22 Out, 2021 | 12:09h

Health Care–Acquired Infections in Low- and Middle-Income Countries and the Role of Infection Prevention and Control – Infectious Disease Clinics of North America

---

Relatório OMS | Mortes por tuberculose aumentaram pela primeira vez em mais de uma década, em virtude da pandemia de COVID-19.

15 Out, 2021 | 16:38h

Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic – World Health Organization

Relatório: Global tuberculosis report 2021

Comentário: Tuberculosis deaths rise for 1st time in years, due to COVID – Associated Press

 

Comentário no Twitter (fio – clique para saber mais)

🆕 WHO's Global TB Report reveals deaths from #tuberculosis rise for the first time in more than a decade due to the #COVID19 pandemic.

1.5 million people died in 2020 & the number will continue to rise unless urgent action is taken 👉https://t.co/RFmWYIelhq #EndTB pic.twitter.com/33G7sI8K2J

— World Health Organization (WHO) (@WHO) October 14, 2021

 

---

Prevalência de anemia em mulheres em idade reprodutiva nos países de baixa e média rendas entre 2000 e 2018.

13 Out, 2021 | 13:13h

Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018 – Nature Medicine

Comentário convidado: Anemia in women — an intractable problem that requires innovative solutions – Nature Medicine

---

Relatório da OMS destaca o déficit global nos investimentos em saúde mental.

12 Out, 2021 | 11:12h

WHO report highlights global shortfall in investment in mental health – World Health Organization

Relatório: Mental Health ATLAS 2020 – World Health Organization

Ver também: World Mental Health Day 2021: Mental health care for all: let’s make it a reality – World Health Organization

 

Comentário no Twitter (fio – clique para saber mais)

The world has failed to provide people with the #MentalHealth services they need: new Mental Health Atlas
Read more➡️https://t.co/J0uKvKWZ46 pic.twitter.com/0wKx6JTV2F

— World Health Organization (WHO) (@WHO) October 8, 2021

 

---

OMS aprova a primeira vacina contra malária para crianças em risco.

8 Out, 2021 | 11:56h

WHO recommends groundbreaking malaria vaccine for children at risk – World Health Organization

Comentários:

WHO Approves First Ever Malaria Vaccine – Health Policy Watch

A historic day for malaria – reaction to WHO decision on the RTS,S vaccine – London School of Hygiene & Tropical Medicine

In major decision, WHO recommends broad rollout of world’s first malaria vaccine – STAT

Why the WHO approval of the first malaria vaccine is a big deal – Vox

WHO greenlights the world’s first malaria vaccine — but it’s not a perfect shot – NPR

The World Health Organization Just Endorsed The World’s First Malaria Vaccine – TIME

WHO Backs Widespread Use Of First Malaria Vaccine – Forbes

World’s 1st malaria vaccine recommended by WHO – LiveScience

 

Comentários no Twitter

I started my career as a #malaria researcher, and I longed for the day that we would have an effective vaccine against this ancient and terrible disease. Today is that day: @WHO is recommending the broad use of the world’s first malaria vaccine. #EndMalaria https://t.co/Oh1O155tYj

— Tedros Adhanom Ghebreyesus (@DrTedros) October 6, 2021

(fio – clique para saber mais)

A child dies from #malaria every two minutes.
One death is one too many.

🚨 Today, WHO recommends RTS,S, a groundbreaking malaria vaccine, to reduce child illness & deaths in areas with moderate and high malaria transmission https://t.co/xSk58nTIV1#VaccinesWork pic.twitter.com/mSECLtRhQs

— World Health Organization (WHO) (@WHO) October 6, 2021

 

---